Dulce Brito, MD, Ph.D, FESC
Dulce Brito, MD, Ph.D, FESC
Cardiology Dpt., Centro Hospitalar Universitário Lisboa Norte, CCUL. Invited Professor of Cardiology
Verified email at medicina.ulisboa.pt
Cited by
Cited by
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart …
AP Maggioni, SD Anker, U Dahlström, G Filippatos, P Ponikowski, ...
European journal of heart failure 15 (10), 1173-1184, 2013
The patient perspective: quality of life in advanced heart failure with frequent hospitalisations
MS Nieminen, K Dickstein, C Fonseca, JM Serrano, J Parissis, F Fedele, ...
International journal of cardiology 191, 256-264, 2015
Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study
R Wachter, M Senni, J Belohlavek, E Straburzynska‐Migaj, KK Witte, ...
European journal of heart failure 21 (8), 998-1007, 2019
In‐hospital and 1‐year mortality associated with diabetes in patients with acute heart failure: results from the ESC‐HFA Heart Failure Long‐Term Registry
G Targher, M Dauriz, C Laroche, PL Temporelli, M Hassanein, ...
European journal of heart failure 19 (1), 54-65, 2017
Levosimendan beyond inotropy and acute heart failure: evidence of pleiotropic effects on the heart and other organs: an expert panel position paper
D Farmakis, J Alvarez, TB Gal, D Brito, F Fedele, C Fonseca, AC Gordon, ...
International journal of cardiology 222, 303-312, 2016
Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in …
PM Seferović, S Stoerk, G Filippatos, V Mareev, A Kavoliuniene, AD Ristić, ...
European journal of heart failure 15 (9), 947-959, 2013
Effects of Serelaxin in Patients with Acute Heart Failure.
RAHFCI Metra M, Teerlink JR, Cotter G, et al.
N Engl J Med. 381 (8), 716-726, 2019
Performance of prognostic risk scores in chronic heart failure patients enrolled in the European Society of Cardiology Heart Failure Long-Term Registry
M Canepa, C Fonseca, O Chioncel, C Laroche, MG Crespo-Leiro, ...
JACC: Heart Failure 6 (6), 452-462, 2018
Acute heart failure congestion and perfusion status–impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA Heart Failure …
O Chioncel, A Mebazaa, AP Maggioni, VP Harjola, G Rosano, C Laroche, ...
European journal of heart failure 21 (11), 1338-1352, 2019
European cardiomyopathy pilot registry: EURObservational research programme of the European society of cardiology
P Elliott, P Charron, JRG Blanes, L Tavazzi, M Tendera, M Konte, ...
European heart journal 37 (2), 164-173, 2016
Physicians' guideline adherence is associated with long‐term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international …
M Komajda, J Schöpe, S Wagenpfeil, L Tavazzi, M Böhm, P Ponikowski, ...
European journal of heart failure 21 (7), 921-929, 2019
Sarcomeric hypertrophic cardiomyopathy: genetic profile in a Portuguese population
D Brito, G Miltenberger-Miltenyi, SV Pereira, D Silva, AN Diogo, ...
Revista portuguesa de cardiologia 31 (9), 577-587, 2012
A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy
FW Friedrich, P Bausero, Y Sun, A Treszl, E Krämer, D Juhr, P Richard, ...
European heart journal 30 (13), 1648-1655, 2009
High resolution melting: improvements in the genetic diagnosis of hypertrophic cardiomyopathy in a Portuguese cohort
S Santos, V Marques, M Pires, L Silveira, H Oliveira, V Lança, D Brito, ...
BMC medical genetics 13 (1), 1-13, 2012
N-Terminal Pro-Brain Natriuretic Peptide Shows Diagnostic Accuracy for Detecting Atrial Fibrillation in Cryptogenic Stroke Patients
AC Fonseca, D Brito, TP e Melo, R Geraldes, P Canhão, LR Caplan, ...
International Journal of Stroke 9 (4), 419-425, 2014
Pela melhoria do tratamento da insuficiência cardíaca em Portugal–documento de consenso
P de peritos subscrita pelo Grupo, NE de Insuficiência Cardíaca, ...
Revista Portuguesa de Cardiologia 36 (1), 1-8, 2017
Familial hypertrophic cardiomyopathy: the same mutation, different prognosis. Comparison of two families with a long follow-up.
D Brito, P Richard, R Isnard, J Pipa, M Komajda, H Madeira
Revista Portuguesa de Cardiologia 22 (12), 1445-1461, 2003
Sacubitril/valsartan eligibility and outcomes in the ESC‐EORP‐HFA Heart Failure Long‐Term Registry: bridging between European Medicines Agency/Food and Drug Administration …
CJ Kapelios, M Lainscak, G Savarese, C Laroche, P Seferovic, ...
European journal of heart failure 21 (11), 1383-1397, 2019
Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
D Brito, JS Matias, L Sargento, MJ Cabral, HC Madeira
Revista portuguesa de cardiologia: orgao oficial da Sociedade Portuguesa de …, 2004
Rationale and design of a multicentre, randomized, placebo‐controlled trial of mirabegron, a Beta3‐adrenergic receptor agonist on left ventricular mass and diastolic function …
AC Pouleur, S Anker, D Brito, O Brosteanu, D Hasenclever, B Casadei, ...
ESC heart failure 5 (5), 830-841, 2018
The system can't perform the operation now. Try again later.
Articles 1–20